Elena Smolyarchuk, chief researcher for the Russian Center for Clinical Research on Medications at Sechenov University, told TASS newswire on Sunday that human trials for the vaccine had been completed and those test patients will be discharged soon.
"The research has been completed and it proved
that the vaccine is safe. The volunteers will be discharged on July 15 and July
20," Smolyarchuk was quoted as saying in the report.
There was no other information on when this vaccine
would enter commercial production.
 |
| Download Manifesto |
Russia had allowed clinical trials of two forms of a
potential coronavirus vaccine developed by the Gamaleya National Research
Center for Epidemiology and Microbiology. The first one was carried out at the
Burdenko Military Hospital. The other vaccine was given to test patients at the
Sechenov First Moscow State Medical University.
Some 20 people volunteered for the injection.
After being given the shot, the volunteers were
asked to quarantine in the hospital for 28 days.
Earlier, results of the Covid-19 vaccine tests performed
on a group of volunteers in Russia showed that they were developing immunity to
the coronavirus, but what the drug actually is was not discussed in the
article.
Russia has reported 719,449 cases of the new SARS
coronavirus. Some 11,188 people have died from complications caused by
Covid-19, the disease caused by the new SARS.
There are at least 21 vaccines currently under trial
worldwide, according to the World Health Organisation. Every country and every
lab is taking a different approach to finding the right solution to stop the
virus from taking over the world at this point.
Meanwhile, in Moscow this weekend, public health
officials lifted the requirements of wearing face masks while outside. Masks
and gloves are mandatory when riding public transportation, going to a medical
center, or while shopping.
From Forbes.com
No comments:
Post a Comment